Harpoon: Merck completes acquisition of Harpoon Therapeutics
Merck, known as MSD outside of the United States and Canada, announced the completion of the acquisition of Harpoon Therapeutics, Inc.
Read full article »
CEO
- -Harpoon is a California-based biotechnology company that researches and develops T-cell immunotherapies for the treatment of cancer and infectious diseases.
Read more